Clinical Trial Update: Efficacy and Safety of Natamycin and Lactulose Vaginal Suppositories in Treatment of Vulvovaginal Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluated the efficacy and safety of natamycin and lactulose vaginal suppositories for vulvovaginal candidiasis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Lactulose vaginal suppositories (lactulose)
• Natamycin vaginal suppositories (natamycin)

Snippet

Sponsor: Avva Rus, JSC | Conditions: Vulvovaginal Candidiasis, Genital | Phase 3 | Status: COMPLETED